Sky Medical Technology Honoured at the Medilink Awards

Sky Scoops Innovation Award at the Medilink North of England Healthcare Business Awards 2020

DARESBURY, England, Feb. 19, 2020 /PRNewswire/ -- Sky Medical Technology, a UK-based medical devices company and manufacturer of the geko device, has today announced its pride in being crowned winner of the Innovation Award at the prestigious Medilink North of England Healthcare Business Awards 2020.

The Medilink Innovation Award recognises Sky's successful partnership with the NHS Royal Stoke University Hospital in generating compelling real-world data that has reported a zero VTE incidence (venous thromboembolism) in immobile acute Stroke patients prescribed the geko device alone - data that has changed clinical practice at the Royal Stoke, driven wider NHS adoption across multiple acute Stroke units and critically, helped Sky achieve FDA 510(k) clearance in the US, making geko the first device of its kind to be cleared by the FDA for VTE prevention across all patients, including non-surgical patients - and a first new approach in 20 years 

With VTE proving a major risk to hospitalised patients – estimates put the number of deaths at 40,000 in England annually, 62 per cent of which are preventable given proper management – acute Stroke patients are a high at-risk population due to reduced mobility.

Collecting the award, Sky CCO Andrew Thelwell said, "I would like to thank Medilink for recognising excellence in technology deployment achieved through outstanding industry and NHS partnering. Partnership makes us who we are and we are enormously proud to bring to market an innovative therapy that completely redefines the way VTE prevention and vascular related conditions can now be treated and to have achieved this in partnership with the Royal Stoke Hospital acute Stroke team."

Commenting on the award, Sky Founder and CEO Bernard Ross said, "Thank you Medilink. We are extremely proud to again be recognised, this time with the prestigious Innovation Award. Not only does it celebrate world-class design and our mission to make prevention easy in stopping life threatening blood clots, it also recognises the high priority we place on partnering with our NHS colleagues who, on top of their full-time jobs, and in a challenging environment, are willing to give-up additional time in pursuit of innovation for the improvement of patient care. It is to the Royal Stoke acute Stroke team that we owe our sincere thanks for the compelling data they have generated to prove geko device efficacy. It is to them we dedicate this award."